{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:51:55Z","timestamp":1791255115425,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Identification and functional analysis of genetic susceptibility genes to coronary heart disease in Inner Mongolia Based on genome-wide association study","award":["2019GG092"],"award-info":[{"award-number":["2019GG092"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The effect of vasodilators in the management of heart failure (HF) remains inconclusive. This study aims to evaluate and compare the overall benefits of vasodilators to patients with HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, Cochrane Library, and Web of Science were searched from database inception to December 27th, 2021. Randomized controlled trials (RCTs) assessing the efficacy of vasodilators in the treatment of HF were included. The Cochrane risk of bias assessment tool was applied to assess the risk of bias of included studies. Meta-analysis was performed using R and Stata 15.0 software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 5517 articles were retrieved, and 18 eligible RCTs were finally included, with 9188 participants. Network meta-analysis showed no difference in the mortality, readmission rate, incidence of adverse cardiovascular events, and serum creatinine (Scr) among different vasodilators. Urapidil was more effective in reducing NT-pro-BNP, compared with nitroglycerin [WMD=-975.64, 95%CI (-1558.32, -320.14)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There are no differences in the efficacy and safety among vasodilators in the management of HF. Especially, although nitroprusside may be the most effective in reducing mortality, there is no significant difference between other drugs. Given the low certainty of the evidence, current evidence suggests that vasodilators have limited efficacy in the routine management of HF. More well-designed RCTs are needed to validate these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>PROSPERO (CRD42022351231).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-06278-7","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:35:55Z","timestamp":1783766155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of vasodilators for heart failure: a systematic review and network meta-analysis of RCTs"],"prefix":"10.1186","volume":"26","author":[{"given":"Qin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"issue":"18","key":"6278_CR1","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"1","key":"6278_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"TA McDonagh","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24(1):4\u2013131.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"6278_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","volume":"13","author":"B Ziaeian","year":"2016","unstructured":"Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat reviews Cardiol. 2016;13(6):368\u201378.","journal-title":"Nat reviews Cardiol"},{"key":"6278_CR4","doi-asserted-by":"crossref","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats A. Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovascular Res. 2022;118(17):3272-3287.","DOI":"10.1093\/cvr\/cvac013"},{"issue":"10120","key":"6278_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","volume":"391","author":"N Conrad","year":"2018","unstructured":"Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, Allison M, Hemingway H, Cleland JG, McMurray JJV, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet (London England). 2018;391(10120):572\u201380.","journal-title":"Lancet (London England)"},{"issue":"14","key":"6278_CR6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa1406656","volume":"372","author":"GA Roth","year":"2015","unstructured":"Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, Naghavi M, Mensah GA, Murray CJ. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372(14):1333\u201341.","journal-title":"N Engl J Med"},{"issue":"16","key":"6278_CR7","first-page":"e240","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr., Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):e240\u2013327.","journal-title":"Circulation"},{"issue":"48","key":"6278_CR8","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1093\/eurheartj\/ehab670","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, et al. Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(48):4901.","journal-title":"Eur Heart J"},{"issue":"17","key":"6278_CR9","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263\u2013421.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"6278_CR10","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","volume":"27","author":"MS Nieminen","year":"2006","unstructured":"Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27(22):2725\u201336.","journal-title":"Eur Heart J"},{"issue":"11","key":"6278_CR11","first-page":"e596","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, et al. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596\u2013646.","journal-title":"Circulation"},{"issue":"5","key":"6278_CR12","first-page":"e35","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35\u201371.","journal-title":"Circulation"},{"issue":"3","key":"6278_CR13","first-page":"e4","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, Bittl JA, Cohen MG, DiMaio JM, Don CW, et al. 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3):e4\u201317.","journal-title":"Circulation"},{"issue":"6","key":"6278_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","volume":"32","author":"BA Borlaug","year":"2011","unstructured":"Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32(6):670\u20139.","journal-title":"Eur Heart J"},{"issue":"9","key":"6278_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/clc.20620","volume":"32","author":"JB Young","year":"2009","unstructured":"Young JB, Cheng M, Mills RM. Hemodynamics, diuretics, and nesiritide: a retrospective VMAC analysis. Clin Cardiol. 2009;32(9):530\u20136.","journal-title":"Clin Cardiol"},{"issue":"1","key":"6278_CR16","doi-asserted-by":"publisher","first-page":"e008545","DOI":"10.1136\/bmjopen-2015-008545","volume":"6","author":"B Gong","year":"2016","unstructured":"Gong B, Wu Z, Li Z. Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials. BMJ open. 2016;6(1):e008545.","journal-title":"BMJ open"},{"key":"6278_CR17","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical Res ed). 2009;339:b2700.","journal-title":"BMJ (Clinical Res ed)"},{"key":"6278_CR18","first-page":"Ed000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:Ed000142.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7650","key":"6278_CR19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"key":"6278_CR20","doi-asserted-by":"publisher","first-page":"m3900","DOI":"10.1136\/bmj.m3900","volume":"371","author":"R Brignardello-Petersen","year":"2020","unstructured":"Brignardello-Petersen R, Florez ID, Izcovich A, Santesso N, Hazlewood G, Alhazanni W, Yepes-Nu\u00f1ez JJ, Tomlinson G, Sch\u00fcnemann HJ, Guyatt GH. GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework. BMJ. 2020;371:m3900.","journal-title":"BMJ"},{"key":"6278_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jclinepi.2021.07.011","volume":"139","author":"R Brignardello-Petersen","year":"2021","unstructured":"Brignardello-Petersen R, Guyatt GH, Mustafa RA, Chu DK, Hultcrantz M, Sch\u00fcnemann HJ, Tomlinson G. GRADE guidelines 33: Addressing imprecision in a network meta-analysis. J Clin Epidemiol. 2021;139:49\u201356.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"6278_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/01.CIR.67.4.817","volume":"67","author":"CV Leier","year":"1983","unstructured":"Leier CV, Huss P, Magorien RD, Unverferth DV. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation. 1983;67(4):817\u201322.","journal-title":"Circulation"},{"issue":"2","key":"6278_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1071-9164(97)90040-3","volume":"3","author":"A Dorszewski","year":"1997","unstructured":"Dorszewski A, G\u00f6hmann E, Dors\u017aewski B, Werner GS, Kreuzer H, Figulla HR. Vasodilation by urapidil in the treatment of chronic congestive heart failure in addition to angiotensin-converting enzyme inhibitors is not beneficial: results of a placebo-controlled, double-blind study. J Card Fail. 1997;3(2):91\u20136.","journal-title":"J Card Fail"},{"key":"6278_CR24","unstructured":"Nct. BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS). https:\/\/www.clinicaltrialsgov\/show\/NCT00186329 2005."},{"key":"6278_CR25","unstructured":"Nct. A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy. https:\/\/www.clinicaltrialsgov\/show\/NCT00270387 2005."},{"issue":"6","key":"6278_CR26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jacc.2006.10.048","volume":"49","author":"RM Mentzer Jr","year":"2007","unstructured":"Mentzer RM Jr, Oz MC, Sladen RN, Graeve AH, Hebeler RF Jr, Luber JM Jr, Smedira NG. Effects of Perioperative Nesiritide in Patients With Left Ventricular Dysfunction Undergoing Cardiac Surgery. The NAPA Trial. J Am Coll Cardiol. 2007;49(6):716\u201326.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6278_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00380-009-1171-0","volume":"25","author":"Q Zhao","year":"2010","unstructured":"Zhao Q, Wu TG, Lin Y, Li B, Luo JY, Wang LX. Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction. Heart Vessels. 2010;25(2):97\u2013103.","journal-title":"Heart Vessels"},{"issue":"3","key":"6278_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cardfail.2010.10.005","volume":"17","author":"SL Chow","year":"2011","unstructured":"Chow SL, O\u2019Barr SA, Peng J, Chew E, Pak F, Quist R, Patel P, Patterson JH, Heywood JT. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure. J Card Fail. 2011;17(3):181\u20137.","journal-title":"J Card Fail"},{"key":"6278_CR29","unstructured":"Chi CI. Effects of recombinant human brain natriuretic peptide on renal function in patients with acute myocardiol infarction and heart failure. https:\/\/www.trialsearchwhoint\/Trial2aspx?TrialID=ChiCTR-IPR-15005796 2014."},{"issue":"2","key":"6278_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/MAJ.0000000000000522","volume":"350","author":"W Yang","year":"2015","unstructured":"Yang W, Zhou YJ, Fu Y, Qin J, Qin S, Chen XM, Guo JC, Hua Q. A multicenter, randomized, trial comparing urapidil and nitroglycerin in multifactor heart failure in the elderly. Am J Med Sci. 2015;350(2):109\u201315.","journal-title":"Am J Med Sci"},{"issue":"4","key":"6278_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00380-015-0642-8","volume":"31","author":"K Xing","year":"2016","unstructured":"Xing K, Fu X, Wang Y, Li W, Gu X, Hao G, Miao Q, Li S, Jiang Y, Fan W, et al. Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI. Heart Vessels. 2016;31(4):490\u20138.","journal-title":"Heart Vessels"},{"issue":"1","key":"6278_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/etm.2016.3302","volume":"12","author":"W Yang","year":"2016","unstructured":"Yang W, Zhou YJ, Fu Y, Qin J, Tan S, Chen XM, Guo JC, Wang DZ, Zhan H, Guan W, et al. Therapeutic effects of intravenous urapidil in elderly patients with hypertension and acute decompensated heart failure: A pilot clinical trial. Experimental therapeutic Med. 2016;12(1):115\u201322.","journal-title":"Experimental therapeutic Med"},{"issue":"6","key":"6278_CR33","first-page":"9729","volume":"10","author":"J He","year":"2017","unstructured":"He J, Wang J, Zhou Y, Fu Y, Qin J, Qin S, Chen X, Guo J, Wang D, Zhan H, et al. Safety and efficacy of urapidil and nitroglycerin in the treatment of elderly patients with acute heart failure: A randomized multi-center parallel-control study in China. Int J Clin Exp Med. 2017;10(6):9729\u201339.","journal-title":"Int J Clin Exp Med"},{"issue":"4","key":"6278_CR34","first-page":"7020","volume":"10","author":"Z Wang","year":"2017","unstructured":"Wang Z, Hua Q, Tan J, Zhou Y, Fu Y, Qin J, Tan S, Chen X, Guo J. Comparison of therapeutic effects between urapidil and nitroglycerin for treatment of acute heart failure with hypertension and atrial fibrillation in elderly patients: A randomized multi-center parallel-control study in China. Int J Clin Exp Med. 2017;10(4):7020\u20139.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"6278_CR35","first-page":"540","volume":"33","author":"H Xu","year":"2017","unstructured":"Xu H, Wang B, Meng Q, Li J, Sun W, Xin L, Chen L. Effectiveness and safety of recombinant human brain natriuretic peptide in the treatment of acute myocardial infarction in elderly in combination with cardiac failure. Pakistan J Med Sci. 2017;33(3):540\u20134.","journal-title":"Pakistan J Med Sci"},{"issue":"1","key":"6278_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3349\/ymj.2017.58.1.105","volume":"58","author":"W Yang","year":"2017","unstructured":"Yang W, Zhou YJ, Fu Y, Qin J, Qin S, Chen XM, Guo JC, Wang Z, Zhan H, Li J, et al. Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial. Yonsei Med J. 2017;58(1):105\u201313.","journal-title":"Yonsei Med J"},{"key":"6278_CR37","doi-asserted-by":"crossref","unstructured":"Zamani P, Akers S, Soto-Calderon H, Beraun M, Koppula MR, Varakantam S, Rawat D, Shiva-Kumar P, Haines PG, Chittams J et al. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction. J Am Heart Association. 2017;6(2):e004262.","DOI":"10.1161\/JAHA.116.004262"},{"issue":"1","key":"6278_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/clc.23023","volume":"42","author":"G Qian","year":"2019","unstructured":"Qian G, Liu CF, Guo J, Dong W, Wang J, Chen Y. Prevention of contrast-induced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure. Clin Cardiol. 2019;42(1):21\u20135.","journal-title":"Clin Cardiol"},{"issue":"1","key":"6278_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1100171","volume":"365","author":"CM O\u2019Connor","year":"2011","unstructured":"O\u2019Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365(1):32\u201343.","journal-title":"N Engl J Med"},{"issue":"10","key":"6278_CR40","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jama.2020.13310","volume":"324","author":"JR Baman","year":"2020","unstructured":"Baman JR, Ahmad FS. Heart Failure. JAMA. 2020;324(10):1015.","journal-title":"JAMA"},{"key":"6278_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/DDDT.S185972","volume":"13","author":"J Shi","year":"2019","unstructured":"Shi J, Li Y, Xing C, Peng P, Shi H, Ding H, Zheng P, Ning G, Feng S. Urapidil, compared to nitroglycerin, has better clinical safety in the treatment of hypertensive patients with acute heart failure: a meta-analysis. Drug Des Devel Ther. 2019;13:161\u201372.","journal-title":"Drug Des Devel Ther"},{"issue":"44","key":"6278_CR42","doi-asserted-by":"publisher","first-page":"e4757","DOI":"10.1097\/MD.0000000000004757","volume":"95","author":"S Zhang","year":"2016","unstructured":"Zhang S, Wang Z. Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis. Medicine. 2016;95(44):e4757.","journal-title":"Medicine"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06278-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06278-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:15:51Z","timestamp":1791252951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06278-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6278"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06278-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"10 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"878"}}